|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001554,
umls-concept:C0001721,
umls-concept:C0012854,
umls-concept:C0019168,
umls-concept:C0019169,
umls-concept:C0021027,
umls-concept:C0023911,
umls-concept:C0040223,
umls-concept:C0441889,
umls-concept:C0442805,
umls-concept:C0547047
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2007-3-19
|
|
pubmed:abstractText |
Administration of hepatitis B immunoglobulin (HBIG) initially after liver transplantation of hepatitis B patients is considered important to prevent reinfection reliably. However, dosing schedules differ considerably between centers. We measured HBsAg, anti-HBs and HBV DNA kinetics to create a rational basis for dosing schemes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:BahrMatthias JMJ,
pubmed-author:FingerAndreaA,
pubmed-author:HoomanNazaninN,
pubmed-author:KlempnauerJürgenJ,
pubmed-author:KreutzThereseT,
pubmed-author:KujawaMatthiasM,
pubmed-author:KuseErnst RER,
pubmed-author:MannsMichael PMP,
pubmed-author:MichelGerdG,
pubmed-author:NashanBjörnB,
pubmed-author:RifaiKinanK,
pubmed-author:RosenauJensJ,
pubmed-author:TillmannHans LHL
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
46
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
635-44
|
|
pubmed:meshHeading |
pubmed-meshheading:17316869-Adult,
pubmed-meshheading:17316869-DNA, Viral,
pubmed-meshheading:17316869-Dose-Response Relationship, Drug,
pubmed-meshheading:17316869-Drug Administration Schedule,
pubmed-meshheading:17316869-Female,
pubmed-meshheading:17316869-Follow-Up Studies,
pubmed-meshheading:17316869-Hepatitis B,
pubmed-meshheading:17316869-Hepatitis B Antibodies,
pubmed-meshheading:17316869-Hepatitis B Surface Antigens,
pubmed-meshheading:17316869-Hepatitis B virus,
pubmed-meshheading:17316869-Humans,
pubmed-meshheading:17316869-Immunization, Passive,
pubmed-meshheading:17316869-Immunoglobulins,
pubmed-meshheading:17316869-Kinetics,
pubmed-meshheading:17316869-Liver Transplantation,
pubmed-meshheading:17316869-Male,
pubmed-meshheading:17316869-Middle Aged,
pubmed-meshheading:17316869-Postoperative Care,
pubmed-meshheading:17316869-Recurrence
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
HBsAg level at time of liver transplantation determines HBsAg decrease and anti-HBs increase and affects HBV DNA decrease during early immunoglobulin administration.
|
|
pubmed:affiliation |
Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Hannover, Germany. Rosenau.Jens@mh-hannover.de
|
|
pubmed:publicationType |
Journal Article
|
